vs
Side-by-side financial comparison of BGSF, INC. (BGSF) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $22.0M, roughly 1.8× BGSF, INC.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -5.3%, a 41.2% gap on every dollar of revenue. On growth, BGSF, INC. posted the faster year-over-year revenue change (-9.4% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $1.7M). Over the past eight quarters, BGSF, INC.'s revenue compounded faster (-5.3% CAGR vs -15.0%).
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
BGSF vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.0M | $39.6M |
| Net Profit | $-1.2M | $14.2M |
| Gross Margin | 35.0% | 73.1% |
| Operating Margin | -17.6% | 32.5% |
| Net Margin | -5.3% | 35.9% |
| Revenue YoY | -9.4% | -10.9% |
| Net Profit YoY | -18.2% | 117.2% |
| EPS (diluted) | $-0.12 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.0M | $39.6M | ||
| Q3 25 | $26.9M | $43.4M | ||
| Q2 25 | $23.5M | $43.4M | ||
| Q1 25 | $20.9M | $47.3M | ||
| Q4 24 | $24.3M | $44.4M | ||
| Q3 24 | $29.8M | $53.1M | ||
| Q2 24 | $25.7M | $53.1M | ||
| Q1 24 | $24.5M | $54.8M |
| Q4 25 | $-1.2M | $14.2M | ||
| Q3 25 | $-5.8M | $12.8M | ||
| Q2 25 | $-3.7M | $2.5M | ||
| Q1 25 | $-722.0K | $21.5M | ||
| Q4 24 | $-981.0K | $6.5M | ||
| Q3 24 | $-804.0K | $2.8M | ||
| Q2 24 | $-761.0K | $18.5M | ||
| Q1 24 | $-792.0K | $18.8M |
| Q4 25 | 35.0% | 73.1% | ||
| Q3 25 | 35.9% | 70.6% | ||
| Q2 25 | 35.8% | 69.2% | ||
| Q1 25 | 36.2% | 79.7% | ||
| Q4 24 | 35.9% | 76.3% | ||
| Q3 24 | 35.9% | 81.5% | ||
| Q2 24 | 37.3% | 74.2% | ||
| Q1 24 | 38.1% | 72.1% |
| Q4 25 | -17.6% | 32.5% | ||
| Q3 25 | -3.5% | 36.6% | ||
| Q2 25 | -18.8% | 33.6% | ||
| Q1 25 | 1.6% | 51.1% | ||
| Q4 24 | -15.7% | 10.6% | ||
| Q3 24 | -3.4% | 26.1% | ||
| Q2 24 | -5.7% | 51.4% | ||
| Q1 24 | 1.7% | 44.6% |
| Q4 25 | -5.3% | 35.9% | ||
| Q3 25 | -21.6% | 29.6% | ||
| Q2 25 | -15.9% | 5.7% | ||
| Q1 25 | -3.5% | 45.4% | ||
| Q4 24 | -4.0% | 14.7% | ||
| Q3 24 | -2.7% | 5.3% | ||
| Q2 24 | -3.0% | 34.8% | ||
| Q1 24 | -3.2% | 34.2% |
| Q4 25 | $-0.12 | $0.15 | ||
| Q3 25 | $-0.52 | $0.12 | ||
| Q2 25 | $-0.34 | $0.02 | ||
| Q1 25 | $-0.06 | $0.21 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-0.07 | $0.03 | ||
| Q2 24 | $-0.07 | $0.20 | ||
| Q1 24 | — | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $48.1M | $248.3M |
| Total Assets | $57.8M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | $41.2M | $127.4M | ||
| Q2 25 | $2.8M | $152.7M | ||
| Q1 25 | $2.0M | $132.1M | ||
| Q4 24 | $32.0K | $125.0M | ||
| Q3 24 | $262 | $137.4M | ||
| Q2 24 | $226 | — | ||
| Q1 24 | $50 | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $48.1M | $248.3M | ||
| Q3 25 | $50.7M | $248.0M | ||
| Q2 25 | $78.3M | $244.6M | ||
| Q1 25 | $81.8M | $226.4M | ||
| Q4 24 | $82.3M | $195.1M | ||
| Q3 24 | $82.9M | $205.0M | ||
| Q2 24 | $83.2M | $8.8M | ||
| Q1 24 | $83.6M | $9.0M |
| Q4 25 | $57.8M | $380.4M | ||
| Q3 25 | $83.6M | $321.4M | ||
| Q2 25 | $149.7M | $315.3M | ||
| Q1 25 | $152.3M | $284.6M | ||
| Q4 24 | $150.1M | $266.1M | ||
| Q3 24 | $157.3K | $296.5M | ||
| Q2 24 | $159.8K | $19.5M | ||
| Q1 24 | $170.6K | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $52.0M |
| Free Cash FlowOCF − Capex | $1.7M | $51.2M |
| FCF MarginFCF / Revenue | 7.6% | 129.3% |
| Capex IntensityCapex / Revenue | 0.1% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0K | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $52.0M | ||
| Q3 25 | $-4.8M | $-20.9M | ||
| Q2 25 | $2.2M | $-8.3M | ||
| Q1 25 | $1.1M | $1.9M | ||
| Q4 24 | $3.2M | $-7.3M | ||
| Q3 24 | $6.5M | $5.0M | ||
| Q2 24 | $7.3M | $19.2M | ||
| Q1 24 | $7.4M | $3.7M |
| Q4 25 | $1.7M | $51.2M | ||
| Q3 25 | $-4.9M | $-20.9M | ||
| Q2 25 | $2.1M | $-8.6M | ||
| Q1 25 | $1.0M | $1.7M | ||
| Q4 24 | $2.5M | $-7.9M | ||
| Q3 24 | $6.5M | $4.6M | ||
| Q2 24 | $7.3M | $18.3M | ||
| Q1 24 | $6.9M | $3.0M |
| Q4 25 | 7.6% | 129.3% | ||
| Q3 25 | -18.1% | -48.3% | ||
| Q2 25 | 9.1% | -19.9% | ||
| Q1 25 | 5.0% | 3.5% | ||
| Q4 24 | 10.2% | -17.8% | ||
| Q3 24 | 21.7% | 8.7% | ||
| Q2 24 | 28.5% | 34.5% | ||
| Q1 24 | 28.1% | 5.4% |
| Q4 25 | 0.1% | 2.0% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 3.0% | 1.3% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 1.6% | ||
| Q1 24 | 2.0% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
